Form S-3 Xilio Therapeutics, Inc.

Go back to Form S-3 Xilio Therapeutics, Inc.

Xilio Therapeutics (XLO) files $250M mixed shelf

May 12, 2026 7:57 AM EDT

Xilio Therapeutics (NASDAQ: XLO) has filed $250,000,000 mixed shelf of:

Common Stock

Preferred Stock

Debt Securities

Units

Warrants


... More